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Resumo
DE-MRI (do ingleˆs delayed enhancement magnetic resonance imaging) consiste numa
te´cnica de imagiologia de ressonaˆncia magne´tica (MRI do ingleˆs Magnetic Resonance
Imaging) com especial aplicac¸a˜o em patologias card´ıacas.
Nos u´ltimos anos, as te´cnicas de imagiologia de ressonaˆncia magne´tica tem desempen-
hado um importante papel no diagno´stico e progno´stico me´dico. Caracter´ısticas vanta-
josas tais como uma elevada resoluc¸a˜o espacial, auseˆncia de radiac¸a˜o ionizante e mu´ltiplas
aplicac¸o˜es impulsionaram o seu uso alargado a va´rias a´reas da medicina moderna.
DE-MRI foi inicialmente desenvolvido para diagno´stico e avaliac¸a˜o de enfarctes do
mioca´rdio (vulgarmente denominado ataque de corac¸a˜o). No entanto, a aplicac¸ao a
doenc¸as isque´micas na˜o e´ exclus´ıva, sendo que recentes estudos demonstraram a sua
utilidade no diagno´stico de outras patologias card´ıacas tais como meta´stases card´ıacas,
infecc¸o˜es virais e condic¸o˜es gene´ticas.
DE-MRI consiste geralmente na aquisic¸a˜o de imagens com ponderac¸a˜o em T1 uti-
lizando uma sequeˆncia IR (do ingleˆs inversion recovery) apo´s injec¸a˜o de um agente de
contraste. Tal como o nome indica delayed enhancement distingue-se das te´cnicas ima-
giolo´gicas de contraste usuais uma vez que o momento de aquisic¸a˜o e´ atrasado por um
determinado per´ıodo de tempo (geralmente entre 10 a 20 min) apo´s injec¸a˜o do agente de
contraste.
O agente de contraste mais frequente em DE-MRI e´ um composto a` base de gadol´ıneo
(Gd) chamado DTPA-Gd (do ingleˆs diethylene-triamine-penta-acid gadolinium). O gadol´ıneo
puro apresenta fortes caracter´ısticas paramagne´ticas, magnetizando-se quando sob o
efeito de um campo magne´tico exterior, sendo por isso natural a sua utilizac¸a˜o como
agente de contraste em MRI. A utilizac¸a˜o de um agente de contraste permite obter con-
traste de sinal entre determinados tecidos atrave´s de um efeito de reduc¸a˜o dos tempos de
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relaxac¸a˜o T1 dos proto˜es circundantes. No entanto, e´ um composto altamente bio-to´xico
e insta´vel, sendo necessa´ria a sua quelac¸a˜o com o composto DTPA para o tornar seguro
em aplicac¸o˜es me´dicas.
Contudo, essa quelac¸a˜o leva a que as mole´culas de Gd apresente um elevado tamanho
molecular, tendo por isso tendeˆncia a acumular em tecidos que sofreram enfarte (tecido
necro´tico) uma vez que estes possuem um alargado espac¸o extracelular em oposic¸a˜o ao
mioca´rdio sauda´vel.
Devido a esta distribuic¸a˜o distinta do agente de contraste pelos tecidos card´ıacos e´
poss´ıvel obter o contraste de sinal entre o mioca´rdio que sofreu enfarcte e o sauda´vel.
Isto porque aquando o momento de aquisic¸a˜o, apo´s o per´ıodo de atraso, o agente de
contraste ja´ tera´ sido eliminado dos tecidos sauda´veis mas ainda permanece em elevadas
concentrac¸o˜es nos tecidos que sofreram enfarcte. Assim, a presenc¸a do Gd em maior
concentrac¸a˜o nestes tecidos ira´ reduzir o tempo de relaxac¸a˜o T1, reflectindo-se numa
elevada intensitade de sinal em imagens com ponderac¸a˜o T1.
Resumindo, numa imagem com ponderac¸a˜o T1, o mioca´rdio que sofreu enfarcte ira´
apresentar elevada intensidade de sinal (tom claro na imagem) comparando com baixa
intensidade de sinal (tom escuro na imagem) do mioca´rdio sauda´vel.
De forma a auxiliar a distinc¸a˜o de sinal entre os dois tecidos, uma sequeˆncia de
gradientes IR e´ geralmente utilizada.
Uma sequeˆncia IR consiste na aplicac¸a˜o de um impulso de radiofrequeˆncia de 180o
despoletado por cada onda R na leitura electrocardiogra´fica (ECG) do paciente. Inicial-
mente, a magnetizac¸a˜o longitudinal (Mz) possui um valor inicial denominado Mz0. Com
a aplicac¸a˜o do impulso de inversa˜o, o vector soma Mz e´ rodado em 180o convertendo
Mz0 em −Mz0. Apo´s o impulso de inversa˜o, a magnetizac¸a˜o longitudinal ira´ enta˜o recu-
perar de −Mz0 a Mz0. O tempo de inversa˜o (TI) caracteriza o per´ıodo de tempo entre a
aplicac¸a˜o do impulso de inversa˜o e o momento de aquisic¸a˜o. O TI e´ selecionado de forma
a coincidir com o ponto nulo de determinado tecido (usualmente o mioca´rdio sauda´vel)
permitindo anular o sinal desse mesmo tecido.
Resumindo, enquanto que por um lado a distribuic¸a˜o diferenciada do agente de
contraste permite aumentar a intensidade de sinal do mioca´rdio que sofreu enfarte, a
aplicac¸a˜o da sequeˆncia IR permite anular o sinal do mioca´rdio sauda´vel. A junc¸a˜o de
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ambos leva a` obtenc¸a˜o do melhor contraste de sinal entre os dois tecidos.
Uma vez que DE-MRI desempenha um important papel na avaliac¸a˜o de doenc¸as
card´ıacas, a procura por uma melhoria na qualidade de imagem e auseˆncia de artefactos,
tem impulsionado va´rios projectos de investigac¸a˜o nos u´ltimos anos. Algumas limitac¸o˜es
inerentes a` te´cnica ainda permanecem por solucionar.
Tratando-se de uma te´cnica cardiac triggered, irregulariedades no batimento card´ıaco
influenciam directamente o comportamento da magnetizac¸a˜o longitudinal e consequente
sinal adquirido. Esta irregulariedade do sinal adquirido leva ao aparecimento de artefactos
na imagem final quando reconstru´ıda.
Este projecto consistiu em avaliar de que forma irregulariedades no batimento card´ıaco
influenciam o sinal adquirido e consequente aparecimento de artefactos na imagem final.
Assim como posterior desenvolvimento e teste de um novo me´todo de reduc¸a˜o de arte-
factos das imagens em pacientes com um batimento card´ıaco irregular.
Diversos me´todos de reduc¸a˜o de artefactos atrave´s da otimizac¸a˜o do TI teˆm sido
apresentados na comunidade cient´ıfica. Estes pretendem diminuir a dispersa˜o do sinal do
mioca´rdio sauda´vel atrave´s de otimizac¸a˜o do TI para cada intervalo card´ıaco. No entanto,
a otimizac¸a˜o do TI e´ dependente de T1 e a minimizac¸a˜o de variac¸o˜es do sinal do mioca´rdio
sauda´vel pode gerar artefactos devido ao sinal proveniente dos restantes tecidos que na˜o
foram corrigidos. O me´todo de correc¸a˜o sugerido nesta dissertac¸a˜o procura eliminar esse
factor e otimizar dinamicamente o TI tendo em conta simultaneamente o sinal de va´rios
tecidos.
O projecto consistiu primeiramente na construc¸a˜o de um ambiente de simulac¸a˜o
nume´rica e posterior implementac¸a˜o em scanner cl´ınico 3T utilizando fantomas exper-
imentais.
O ambiente de simulac¸a˜o encontra-se dividido em va´rias func¸o˜es modulares. Uma
primeira func¸a˜o permite obter um registo simulado de ECG, representando o nosso pa-
ciente virtual, podendo simular diferentes intervalos de tempo entre picos R com um
determinado desvio-padra˜o (10%,20%...etc.) da me´dia de batimento card´ıaco.
De seguida, uma segunda func¸a˜o calcula a intensidade de sinal ao longo de cada janela
de aquisic¸a˜o tendo em considerac¸a˜o diversos paraˆmetros iniciais. Sendo os principais: TI,
TR (tempo de repetic¸a˜o), TE (tempo de eco), o sinal de ECG e o factor de aquisic¸a˜o. O
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factor de aquisic¸a˜o (N) permite definir o nu´mero de pontos do espac¸o-K adquiridos por
cada janela de aquisic¸a˜o.
Uma terceira func¸a˜o modular simula a aquisic¸a˜o de imagens 2D utilizando como input :
um fantoma virtual, a intensidade de sinal previamente calculada e uma trajecto´ria de
aquisic¸a˜o no espac¸o-K. O fantoma virtual utilizado pretende representar um corte de curto
eixo do ventr´ıculo esquerdo com treˆs tecidos presentes: mioca´rdio que sofreu enfarte,
massa de sangue no interior do ventr´ıculo e mioca´rdio sauda´vel. De seguida, cada ponto
de intensidade do sinal de cada vez pre´-calculado atrave´s do T1 do tecido correspondente
e´ atribuido a` ma´scara do tecido correspondente no fantoma virtual. Apo´s soma das
treˆs ma´scaras de intensidade (treˆs tecidos)e aplicac¸a˜o de uma transformada de Fourier
(FFT), o espac¸o-K final e´ obtido. Posteriormente, a trajecto´ria de aquisic¸a˜o do espac¸o-K
e´ utilizada de forma a re-organizar a ordem em que este e´ preenchido. Por u´ltimo, apo´s
transformac¸a˜o do espac¸o K atrave´s de uma transformada inversa de Fourier (IFFT) (do
ingleˆs Inverse Fast Fourier Transform), obte´m-se a imagem final reconstruida.
A quarta func¸a˜o modular aplica o me´todo de correc¸a˜o de artefactos por otimizac¸a˜o do
TI. O principal objectivo consiste em determinar o TI o´timo (TIopt) que corresponde a`
minimizac¸a˜o de variac¸o˜es do sinal (SSEtotal) dos va´rios tecidos considerados: SSEtotal =
W ∗SSEmyocardium + (1−W ) ∗SSEblood. Onde W e´ o factor que permite contra-balanc¸ar
a correc¸a˜o dando mais ponderac¸a˜o a artefactos origina´rios do sangue (W<0.5) ou do
mioca´rdio sauda´vel (W>0.5).
Por u´ltimo, o me´todo proposto foi implementado em scanner cl´ınico Philips 3T uti-
lizando fantomas de gel de forma a representar os treˆs tipos de tecidos (mioca´rdio que
sofreu enfarte, sangue e mioca´rdio sauda´vel). Para aquisic¸a˜o dos dados em scanner, os
mesmos paraˆmetros de aquisic¸a˜o e sinal de ECG previamente calculados no ambiente de
simulac¸a˜o, foram utilizados.
Resultados obtidos com a simulac¸a˜o nume´rica confirmaram que um batimento card´ıaco
irregular afecta directamente o comportamento do sinal adquirido. Por exemplo para
50% de variac¸a˜o do batimento card´ıaco, o sinal do mioca´rdio sauda´vel apresentou mais
de 85% de dispersa˜o em relac¸a˜o ao valor me´dio enquanto que o sangue revelou quase
30% de desvio. Verificou-se tambe´m que irregulariedades do batimento card´ıaco levam a
maiores desvios de intensidade do sinal do mioca´rdio sauda´vel e do sangue. Para ale´m
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disso, a simulac¸a˜o de imagens 2D revelou o aparecimento de artefactos com intensidade
crescente de acordo com a intensidade de variac¸a˜o do batimento card´ıaco.
Implementac¸a˜o do me´todo de otimizac¸a˜o do TI foi executada com sucesso e revelou
resultados positivos. Medic¸o˜es do n´ıvel geral de artefactos da imagem simulada para
diferentes valores de W, permitiram concluir que o valor o´timo de W corresponde a 0,4.
Para uma situac¸a˜o de 50% de variac¸a˜o do batimento card´ıaco e utilizando o me´todo
de correc¸a˜o com W=0,4, verificou-se uma diminuic¸a˜o na variac¸a˜o do sinal do mioca´rdio
sauda´vel de 90 % para aproximadamente 25% e no sinal do sangue de 20% para menos de
10%. Tal como esperado, uma reduc¸a˜o na variac¸a˜o de intensidade do sinal reflectiu-se na
diminuic¸a˜o da quantidade de artefactos na imagem final. Assim, verificou-se uma reduc¸a˜o
de 70% dos artefactos comparando com uma imagem na˜o corrigida. Correspondendo 20
e 30 % mais comparando com corrigir apenas um tecido de cada vez, sangue e mioca´rdio
sauda´vel respectivamente.
Resultados similares foram obtidos nos dados experimentais adquiridos no scanner,
com similar reduc¸a˜o do n´ıvel de artefactos na imagem final. Medic¸a˜o do n´ıvel de artefactos
nas imagens 2D dos fantomas experimentais levaram a` conclusa˜o que o me´todo permitiu
reduzir ainda mais o n´ıvel de artefactos comparando com os dados simulados. Com o
me´todo de otimizac¸a˜o do TI a W=0.4, a imagem apresentou uma reduc¸a˜o de mais de
40% comparando com uma correc¸a˜o de apenas o mioca´rdio sauda´vel.
Resumindo, os resultados experimentais foram coincidentes com os resultados simu-
lados e parecem suportar a conclusa˜o que a otimizac¸a˜o do TI tendo em conta mu´ltiplos
tecidos reduz com sucesso a quantidade de artefactos em imagens DE. No entanto, o es-
tudo apresenta algumas limitac¸o˜es. Os valores de T1 dos fantomas experimentais foram
determinados atrave´s de uma sequeˆncia Look-Locker. No entanto, alguns resultados obti-
dos sugeriram que a errada estimac¸a˜o dos valores de T1 podera´ ter ocorrido, o que levou
ao desvio nos resultados obtidos.
Aspectos como variar a me´dia do batimento card´ıaco para valores inferiores ou supe-
riores, teste diferentes trajecto´rias de aquisic¸a˜o do espac¸o-K, novo teste dos valores de
T1 dos fantomas, assim como determinac¸a˜o dos paraˆmetros de aquisic¸a˜o para imagens
in-vivo sa˜o importantes aspectos a considerar em estudos futuros.
Em conclusa˜o, este estudo contribuiu positivamente para um conhecimento mais
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alargado em termos da diminuic¸a˜o de artefactos imagens DE-MRI. Concluiu-se que uma
abordagem a` otimizac¸a˜o de TI onde mu´ltiplos tecidos sa˜o considerados apresenta vanta-
gens relativamente a` abordagem em que apenas a contribuic¸a˜o do mioca´rdio sauda´vel e´
tida em conta.
Palavras-chave: DE-MRI (Delayed enhancement Magnetic Resonance Imaging),
Tempo de inversa˜o (TI), Enfarcte do mioca´rdio, Batimento card´ıaco irregular
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Abstract
Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) is a widely used imaging
tool in the assessment of ischemic pathologies, crucial in distinguishing between infarcted
and healthy myocardium [1]. Usually, T1 weighted images are acquired using an Elec-
trocardiogram (ECG) triggered Inversion Recovery (IR) sequence after contrast agent
injection which allows to increase signal contrast between the two tissues.
Since DE-MRI is cardiac triggered, heart rate (HR) irregularities directly affect signal
behaviour. When HR varies, the time for the longitudinal magnetization (Mz) to recover
is different for each cycle which leads to a different amount of magnetization available for
acquisition. This irregular signal intensity can cause strong image artefacts.
Therefore, the purpose of this study was to develop a novel acquisition approach
to compensate for HR variations using a multi-tissue model. Optimal Inversion Time
(TI) values for each cycle were obtained by minimizing Mz variations of the healthy
myocardium (SSEmyocardium) and blood (SSEblood): SSEtotal = W ∗ SSEmyocardium +
(1−W )∗SSEblood. The weighting (W) allows to correct more strongly for artefacts from
blood (W < 0.5) or myocardium (W>0.5) to achieve the best image quality possible.
Simulations were performed to study signal behaviour and test the proposed multi-
tissue correction approach. In addition, the method was also implemented on a 3T
scanner and phantom experiments verified the simulated results.
The proposed multi-tissue method was successful when compensating for artefacts.
For 30% HR variation scenario, it reduced image artefacts by approximately 70 % com-
pared with a non-corrected image which is 20 and 45 % more than the single-tissue
approach, only blood or healthy myocardium respectively.
In conclusion, not only the proposed multi-tissue method can be successfully used to
reduce image artefacts, but also leads to a better image quality than some previously
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presented approaches with a single tissue correction.
Keywords: DE-MRI, ischemic heart disease, inversion time (TI), irregular heart
rate, arrhythmia
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Chapter 1
Introduction
The present dissertation describes the project developed by the author to complete an
Integrated Master degree in Biomedical Engineering and Biophysics - Radiation in Di-
agnosis and Therapy profile, at Faculdade de Cieˆncias, Universidade de Lisboa (FCUL),
Portugal.
The project was developed at the Division of Imaging Sciences and Biomedical Engi-
neering, KCL, United Kingdom (UK). This was under the LLP/Erasmus student inter-
change program for a period of eight months between October 2012 and May 2013.
During this project a novel approach to reduce artefacts due to heart rate variations
in DE-MRI was developed.
Professor Tobias Schaeffter, deputy head of the Division of Imaging Sciences and
Biomedical Engineering, with extensive experience in imaging sciences was the external
supervisor. Close collaboration with Dr. Christoph Kolbitsch, post-doctoral associate at
the department, was also crucial for the project accomplishment.
Professor Rita Nunes, post-doctoral researcher at the Instituto de Biof´ısica e Engen-
haria Biome´dica (IBEB), FCUL and assistant teacher at FCUL was the internal super-
visor. Professor Nunes works mainly at IBEB but also has current projects at KCL,
allowing to establish the contact between the two research groups.
1
CHAPTER 1. INTRODUCTION
1.1 Project background
Since the 1980s MRI has been used to assess myocardial infarction with the use of contrast
agents [2]. Commonly, T1 weighted images are obtained using a cardiac triggered IR
gradient echo sequence after contrast agent injection [3–5].
This leads to a high signal contrast and consequent distinction between the my-
ocardium that has suffered irreversible infarction (necrotic tissue) and the healthy my-
ocardium, being a useful tool for physicians to evaluate the extent of non-viable my-
ocardium and therapeutic course in a wide set of cardiac pathologies.
Any cardiac MRI technique is challenging due to the cardiac and respiratory chest
motion. This can be usually compensated for with cardiac triggering, where data is
acquired in the period where the heart is more steady (mid-diastole), and breath hold or
respiratory navigators [6].
However, patients with irregular heart rates still pose a major challenge for DE-MRI.
Since it is cardiac triggered technique, irregular heart rate can directly influence the ac-
quired MR signal. When the heat rate varies, the time for the longitudinal magnetization
to recover is different for each cardiac cycle which leads to a different amount of magne-
tization available at the time of data acquisition. This irregular magnetization behaviour
leads to a variation of the acquired signal, causing strong artefacts when the final image
is reconstructed [7].
As DE-MRI becomes a widely used cardiac imaging tool, the demand for high quality
images increases proportionally and several studies have been presented to compensate
for this limitation in the past few years [8–10].
Most methods compensate for this limitation by adapting the TI for each cardiac
cycle to ensure the healthy myocardium signal is always nulled [8, 9]. Nevertheless this
TI correction is T1 dependent and correcting for the healthy myocardium can create
artefacts arising from other tissue types, such as from the blood pool.
The overall goal of the project was to develop a method to reduce artefacts due to
arrhythmia considering a multi-tissue approach. The main goal is to correct the TI
such that the magnetization available at acquisition remains as stable as possible. A
more stable magnetization behaviour will translate in a final image with fewer and less
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pronounced artefacts.
Firstly, a numerical simulation was built to study signal behaviour under the influence
of irregular HR and develop the novel correction method. Secondly, the correction method
was implemented at a 3T scanner using the same parameters. Experimental data from
gel phantoms was used to validate simulated results.
1.2 Thesis outline
This thesis is divided into 5 chapters. Chapter 1 is the current chapter. A brief resume
of the project background, respective supervisors and development is given.
Chapter 2 presents a background introduction to important concepts of DE-MRI.
Technical aspects of the technique are explained such as medical applications, functioning
of an IR sequence acquisition, choice of the TI and main limitations of DE-MR images. In
addition, a brief explanation of current image artefacts correction methods is also given.
Chapter 3 refers to the first portion of this dissertation study, the built of a numerical
simulation environment. Methodology referring to the construction of the simulation
environment as structure, main functions, mathematical description of the signal and
parameters used, can be found in this chapter. In addition, the simulated results are also
presented.
Chapter 4 presents the second portion of the study: phantom experiments in a 3T
scanner. Both the methodology and results referring to the scanner experiments are
shown.
Chapter 5 is a summary of this dissertation, including the conclusions drawn from
the study, its contribution for the scientific community, main limitations and recommen-
dations for future studies in the field.
3
Chapter 2
Delayed Enhancement MRI:
theoretical background
2.1 Introductory considerations
In DE-MRI, T1 weighted images are usually obtained using a cardiac triggered IR se-
quence acquisition after contrast injection. DE imaging is most commonly used for dis-
crimination between healthy myocardium and infarcted myocardium, for medical diag-
nosis and therapeutic establishment purposes [1, 11].
As the name indicates, delayed enhancement imaging distinguishes itself from en-
hancement imaging by delaying the acquisition by a certain period of time (usually be-
tween 10 to 20 minutes) after contrast injection [12]. Therefore this technique allows to
differentiate the tissues based on their distinct wash-out times [1]. A slower wash-out
rate directly relates to a larger concentration of the contrast agent left in the tissue when
acquisition is performed. Since the most commonly used contrast agents cause a short-
ening effect of the T1 relaxation time, tissues with a higher concentration of the agent
will present a shorter T1 value and thus a higher signal intensity in the final image.
In addition, a proper adjustment of the IR pulse sequence (i.e. selecting the inversion
time such that the obtained signal from the healthy myocardium is null) increases the
signal contrast between the healthy and infarcted myocardium.
The next sections of this chapter explore in depth these two main aspects of DE
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imaging, as well as medical applications and limitations underlying this technique.
2.2 Ischemic heart disease and DE imaging medical
applications
Ischemic heart disease is the leading cause of death in adults in the world. In 2011 alone,
approximately 7 million people died from ischemic heart disease [13].
Ischemic heart disease (or Myocardium infarction (MI)) is a heart pathology charac-
terized by the malfunction of the heart wall due to partial or complete obstruction of the
blood supply (ischemia). Ischemia causes a shortage of oxygen and vital nutrients to the
correct functioning of the heart muscle.
In most patients, ischemic heart disease is related to another pathology called Coro-
nary artery disease (CAD). CAD is characterized by the formation of an atherosclerosis
plaque (substance made of cholesterol, fat and blood compounds) [14] which can lead
to the hardening and narrowing of the coronary arteries [15]. The two coronary arteries
(left and right) are responsible for irrigating the heart muscle. CAD and consequent
malfunction of those arteries lead to heart muscle ischemia.
The myocardium can be affected to several degrees, from infarcted myocaridum
(necrotic tissue) to hibernated myocardium. While hibernated myocardium presents
minimum contractile function due to restricted blood supply but can recover after vas-
cularization therapy, infarcted myocardium presents permanent cell destruction [16].
Additionally in clinical terms, distinction between acute and chronic MI is considered.
Acute MI is usually characterized by necrotic cells (ruptured cellular membrane) and an
enlarged extracellular volume. On the other hand, in chronic MI the absence of cells
for a prolonged period led to the formation of a collagen matrix (fibrotic tissue) [1, 15].
Representation of both MI types and an healthy myocardium can be seen in Fig. 2.1.
Currently, Single photon emission tomography (SPECT) is one of the most common
techniques used when assessing MI, since it can directly indicate metabolic function of
the myocardium cells [17]. Nevertheless, it yields low spatial resolution images and does
not provide high detailed information. MRI not only presents higher spatial resolution, it
5
CHAPTER 2. DELAYED ENHANCEMENT MRI: THEORETICAL BACKGROUND
Figure 2.1: Representation of a healthy myocardium with intact cells, acute MI with ruptured
cell membranes leading to cellular death and chronic MI with formation of fibrotic tissue. (Image
modified from [1])
also leads to higher reliability for some types of MI that are undetectable with SPECT. In
a study by Wagner et al, MRI was reported to correctly identify 92% of sub-endocardial
infarction segments while SPECT was only able to identify 30% [18].
Due to a higher spatial resolution, absence of ionizing radiation and multiplicity of
applications, DE-MRI has become a well accepted alternative for cardiac diagnosis.
When dealing with MI patients, assessment of myocardium viability is crucial for
predicting heart function recovery chance, deciding on a therapy course and calculating
patient re-incidence rate. Assessment of myocardium viability consists in distinguishing
between hibernated myocardium and infarcted myocardium.
In DE imaging, infarcted tissue usually presents enhancement after contrast injec-
tion while hibernated myocardium does not. Previous studies proved that tissue showing
enhancement (infarcted myocardium) continue to show lack of contraction even after vas-
cularization therapy [19,20]. Thus supporting the theory ”bright is dead” where enhanced
tissue is most likely irreversibly damaged [21]. In summary, enhancement in a certain
portion of the heart wall in DE imaging is most likely related with infarcted myocardium.
High reliability of MRI when matching infarct size to histology measurements (Fig.
2.2) was shown by Wagner et al. A high correlation coefficient (R=0.98) was reported
between infarction size assessed with DE-MRI and assessed with histology measurements
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[18].
Figure 2.2: (Top) Short axis view of the heart obtained with DE-MRI showing enhanced
myocardium infarction. (Down) Correspondent histological slices with correspondent MI areas
[18].
Another positive aspect of DE-MRI is that both acute and chronic MI show enhance-
ment (Fig. 2.3). Nevertheless, some disagreement is still present regarding whether
DE-MRI can be useful in distinguishing between the two of them. One current sugges-
tion refers to using the presence of oedema (tissue swelling due to water accumulation) as
the differentiating factor since it is only present in acute MI. Since water usually presents
a long T1 and T2 values comparing with healthy myocardium, signal contrast arises be-
tween the oedema (acute MI) and the healthy myocardium. Current studies reported
good results when identifying oedema in acute MI [22,23]. This is accomplished by using
a technique that uses both DE imaging and T2 weighted images.
DE-MRI can also be used to predict muscle function recovery after therapy. Previous
studies presented evaluation of transmural extent of infarction area as a way to predict
contractile improvement after therapy [24,25]. For example, Choi et al. study concluded
that when the percentage of tissue that showed improvement was reduced, the transmural
enhanced infarction area increased. For segments with 1 to 20% infarction extent, around
67% showed contractible improvement but for 76% infarction extent in DE imaging, only
5% showed function improvement [24].
This conclusions can be useful when assessing a patient course of therapy and chance
of contractile recovery even before therapy is applied.
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Figure 2.3: (a) Short axis DE-MRI view of the heart showing acute transmural MI. Enhance-
ment of the infarcted myocardium is visible (arrows) compared to a null signal from the healthy
myocardium (dark tone). (b) Short axis DE-MRI view of the hear from the same patient one
year later (chronic MI). Infarcted myocardium continues to show enhancement and also shows
thinning of the infarcted area compared to the acute MI phase [16].
DE might also be useful in patients with no previous history of myocardium infarction
episodes but diagnosed CAD. It was reported that 81% of the patients with CAD, diag-
nosed by X-ray angiography, showed delayed enhancement compared to only 8% in the
control group. Therefore, DE might be a valid alternative to ionizing radiation methods
when evaluating CAD patients and preventing future heart failure episodes [17].
While assessment of ischemic heart diseases is the most common usage for DE imaging,
it is not exclusive and can be seen in a wide range of cardiac pathologies. A few examples
are inflammatory diseases of the myocardium, cardiac neoplasms or genetic conditions
[16].
2.3 Physiologic basis and contrast agent behaviour
Myocardium infarction assessment using DE imaging relies on different wash-out rates of
the contrast agent and consequent effects on T1 values of the cardiac tissues.
The majority of contrast agents work by altering the T1 and T2 relaxation times of
the surrounding tissues. According to the model described by Bloembergen, Purcell and
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Pound [26], the effect of contrast agents on T1 and T2 relaxation times can be described
by:
1
T1
=
1
T1,0
+R1na (2.1)
1
T2
=
1
T2,0
+R2na (2.2)
Where T1 and T2 are the relaxation times with contrast agent influence, T1,0 and T2,0
are the relaxation times in the absence of contrast agent, na is the agent’s concentration
and R1 and R2 are the agent’s relaxivity values. Relaxivity quantifies the ability of a
certain compound to change the relaxation rates of the surrounding proton spins per
molar concentration.
The most commonly used agent in DE-MRI is a Gadolinium (Gd) based compound
called DTPA-Gd. The gadolinium atom has seven unpaired electrons, giving it strong
paramagnetic properties and becoming strongly magnetized when placed in an external
magnetic field. Nevertheless, Gd is highly toxic in it’s pure state, being necessary to
chelate it with another compound called Diethylene-Triamine-Penta-acid (DTPA). Thus
making Gd thermodynamically more stable and biologically safer [27].
Gadolinium based agents comply to Equations 2.1 and 2.2 and present high values of
relaxivity thereby shortening T1 and T2 times of surrounding tissues.
Distinct distribution of the agent in DE-MRI depends not only on the Gd kinetics but
also on physiological characteristics of the heart tissues involved. Due to the chelation
with DTPA, Gd presents a large molecular weight, having tendency to accumulate in
tissues with larger extracellular volume [15]. Since tissues that suffered infarction usually
present an enlarged extracellular space (Section 2.2), they tend to accumulate higher
amounts of the contrast agent.
In addition, the delay period between contrast injection and acquisition ensures that
most of the contrast agent has already washed out from the healthy tissue but remains
in higher concentration in MI tissues.
In conclusion, tissues with higher Gd concentration (infarcted tissue) have a shorter
T1 value and consequently appear bright on T1-weighted images. On the other hand,
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tissues with longer T1 values (less Gd concentration) appear darker, such as the healthy
myocardium. The blood pool tends to present an intermediate T1 value.
2.4 Inversion recovery pulse sequence and inversion
time
Distinct distribution of the contrast agent between the different heart tissues allows for the
infarcted myocardium to be slightly more enhanced than the healthy tissue. In addition,
an IR pulse sequence is usually used to achieve the best signal contrast possible between
the two tissue types [28].
Inversion recovery is a gradient echo pulse sequence where a 180o pulse precedes
a gradient echo read-out. However, 2D MR images relate to a large amount of data
and image acquisition has to be divided into several sections (over several acquisition
windows). In addition, the acquisition window length is limited by mid-diastole, thus a
limit number of K-space lines can be sampled per cardiac cycle. Thereby the read-out
portion is repeated N times to allow acquisition of multiple data points per inversion
pulse (Fig. 2.4) [15].
Initially, the magnitude of the net vector of longitudinal magnetization is positive and
described as Mz0. Application of the inversion pulse flips the magnetization vector by
180o transformingMz0 into −Mz0. After the IR pulse, longitudinal relaxation occurs [15]:
Mz(t) = Mz,eq(1− 2e− tT1 ) (2.3)
Where T1 is the longitudinal relaxation parameter and Mz,eq the magnetization at
equilibrium. Longitudinal relaxation curves (Equation 2.3), without considering read-out,
for healthy and infarcted myocardium can be seen in Fig. 2.5.
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Figure 2.4: Inversion recovery gradient echo sequence diagram. Firstly an 180o Radio Fre-
quency (RF) pulse is applied to cause inversion of the net Mz vector, followed by a gradient
echo read-out (inside brackets). The brackets portion can be applied several times per cardiac
cycle to allow the acquisition of multiple segments within the same inversion pulse. The ex-
citation RF pulse is applied, flipping the available longitudinal magnetization towards the xy-
plane by the angle defined by α. Secondly, the echo is obtained through application of a bipolar
frequency-encoding gradient (Gx). Firstly to dephase the protons spins and the secondly as
frequency read-out. Gy gradient defines the phase-encoding gradient that allows to define the
K-space line that it is being sampled. The Gz gradient is the slice selection gradient allowing
to select the 2D slice. Finally, the ADC (analogue to digital converter) allows for the signal to
be acquired [15].
The time point where the magnetization is zero (null point) depends on T1 and can be
used to null the signal from a chosen tissue. The time period between the inversion pulse
and excitation is the TI. This is usually selected such that the healthy myocardium signal
is null, relating to the best signal contrast between healthy and infarcted myocardium [1].
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Figure 2.5: Longitudinal magnetization relaxation curves for healthy myocardium (longer
T1) and infarcted myocardium (shorter T1) after application of an IR pulse. The ”null point”
corresponds to the time point for which the healthy myocardium signal is null [2].
2.4.1 Selecting the time of inversion
Selecting the appropriate TI is a crucial step to obtain a good image quality and a
diminished level of artefacts.
Nevertheless, several drawbacks can be encountered. Firstly, the TI varies from pa-
tient to patient and so it is empirically determined for each subject [29]. Secondly, it also
depends on several factors such as: contrast agent administrated dose, cardiac function,
time after contrast injection, among others [28].
Mathematically it is possible to determine the appropriate TI from its dependency of
the T1 of the healthy myocardium. Following from Equation 2.3, the tissue signal is null
when Mz(TInull) = 0, therefore TI can be estimated:
Mz(TInull) = Mz,eq(1− 2e−
TInull
T1 ) = 0 (2.4)
TInull = −T1ln(2) (2.5)
However, in in-vivo situations, it is not possible to know the accurate value of T1 of
the myocardium a priori.
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Several methods are presented throughout the literature to determine the optimal TI,
for example, using cine MR scout images or T1 mapping measurements [28,30].
Using cine IR images to estimate TI is a trial and error technique. After the usual 180o
IR pulse is applied, a fast steady-state free precession readout is implemented allowing to
acquire multiple images along the longitudinal recovery curve, correspondent to different
TI values (Fig. 2.10). The optimal TI corresponds to the visually selected image where
the healthy myocardium appears to have a null signal [28].
As an alternative, the TI can be estimated through direct T1 mapping measurements
[15, 30] using a Look-Locker sequence [31]. This allows to more accurately estimate T1
of the healthy myocardium and correspondent adequate TI (Equation 2.5).
The incorrect selection of the inversion time can lead to image artefacts and mislead
during evaluation of the myocardial infarction (Section 2.5).
2.4.2 Imaging time after contrast agent injection
As equally important as the selecting the correct TI, choosing the imaging time after
contrast injection is another major concern in DE-MRI.
Each tissue signal intensity directly depends on the present Gd concentration level
within the tissue at the time of acquisition (Section 2.3). However, Gd concentration
doesn’t remain steady and gradually washes out with imaging time. Thereby, the chosen
TI might no longer be adequate and needs to be adjusted if acquisition takes too long [2].
Figure 2.6 shows the direct relation between Gd concentration and the TI value.
Exponential decrease of plasma Gd concentration with time (solid line) is based on real
data acquired by Weinmann et al for a Gd injection dose of 0,125 mmol/Kg [32]. The
dashed line describes the correct TI necessary to null the myocardium calculated from
Gd concentration at a given time [33]. For example, at 5 minutes after injection, the
correct TI is estimated to be approximately 304 ms.
The idea to keep in mind is that diminished Gd concentration translates to a weaker
T1 shortening effect resulting in tissue with a longer T1 and consequent need to increase
the TI [33]. Correct estimation of the TI might be possible but it is important to consider
that it is transient for each cardiac cycle and if acquisition takes too long, it might no
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longer be nulling the myocardium signal for the last data points acquired.
Figure 2.6: Concentration of Gd plasma as a function of time after injection (solid line) and
appropriate TI for correspondent Gd concentration (dash line). As imaging time after injection
increases, the adequate TI for a certain dose of Gd also increases [2].
In addition, another study suggested that imaging time after contrast injection can
also affect infarct size estimation. Oshinki et al suggested that for a Gd dose of 0,03
mmol/kg, data should be acquired at 21 ± 4 minutes after injection so that the enhanced
area matches true MI size. On the other hand, images acquired right after injection
(within the 10 minutes range) overestimated infarcted size by 20-40 % [34].
In conclusion, both studies seem to suggest that imaging time after injection plays a
crucial role in ensuring correct signal nulling of the myocardium.
2.4.3 Repeated IR time sequence and triggering
A repeated IR sequence is usually applied to allow acquisition of a segmented 2D image
matrix over several acquisition cycles.
A schematic representation of a repeated IR acquisition is shown in Fig. 2.7.
Each IR pulse is triggered by an R-peak on the ECG signal. However, a delay period
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Figure 2.7: Schematic representation of longitudinal magnetization from the healthy my-
ocardium along a repeated IR sequence. The first cycle represents a steady HR (mean R-R
length) while the second cycle represents an irregular HR situation (longer interval than mean
R-R).
(TD) introduced between the R-peak triggering and inversion pulse application, allows
for acquisition to occur in mid-diastole. After the IR pulse, −Mz0 is allowed to recover
until Ma (Mz available at acquisition) when the read-out sequence portion is applied.
The TI is selected such that acquisition begins at the time point for which the healthy
myocardium signal is null. The MR signal can then be acquired by flipping Ma towards
the xy-plane (Mxy). During acquisition (dashed box), several consecutive acquisition
pulses (α), equidistant by a time period TR, are applied to acquire multiple data points.
Acquisition is set to last for a time period TA. Finally, the last Mxy point is allowed to
recover until M+ (Mz available before the next inversion) for a period of time T0.
If the heart rate is steady (mean R-R length), the following equation is found:
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RR = TI + TA+ T0 (2.6)
If the heart beat is irregular, an extra ∆t can either be positive (R-R interval is longer
than mean R-R) or negative (R-R interval is shorter than the mean):
RR = TI + TA+ T0 ±∆t (2.7)
In terms of triggering, DE imaging can use R-R or 2R-R (Fig. 2.8). This means that
the IR pulse can either be applied for every R peak occurrence (R-R) or for every other R
peak (2 R-R). Using a R-R gating reduces the amount of time available between IR pulses
which leading to incomplete magnetization recovery. On the contrary, a 2R-R gating
allows for a more complete magnetization recovery and is specially recommended for
tachycardia patients. However, 2 R-R gating does require twice the acquisition time [1].
Figure 2.8: (Top) Mz behaviour when R-R gating is used leading to incomplete magnetization
recovery. (Bottom) Mz behaviour when 2R-R gating is considered, improving magnetization
recovery and allowing to obtain higher signal intensity [1].
2.5 Image artefacts and limitations
A major concern in DE-MRI, as in any cardiac imaging modality, is the presence of image
artefacts due to cardiac motion.
For DE-MRI restricting data acquisition to a so-called acquisition window placed dur-
ing the mid-diastolic period is usually a successful compensation technique [6]. However,
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not only there is cardiac motion but respiratory motion of the chest as well. The latter
is usually compensated for by breath-holding or respiratory navigation approaches.
Nevertheless when those are deficient, specific artefacts can be identified. Deficient
breath holding usually causes ghosting of chest area while poor cardiac gating causes
ghosting of the heart itself (Fig. 2.9).
Figure 2.9: Image DE-MRI showing: (a) ghosting artefacts of the overall chest area due to
deficient breath holding (b) ghosting artefacts of the heart itself due to poor cardiac gating (c)
no ghosting artefacts due to acquisition with correct breath hold and gating [6].
When imaging tachycardia patients, it is crucial to use 2R-R or even 3R-R gating to
allow for complete magnetization recovery. That will ensure higher signal intensity and
less ghosting artefacts [1].
Patients with tachycardia also present another challenge to DE imaging since their
mid-diastole period is usually shorter. To reduce ghosting due to heart movement, the
acquisition window duration has to be shortened with less K-space lines sampled per
window [6].
Another source of inaccurate images can be the incorrect choice of TI (Fig. 2.10).
When the TI is selected too short (TI−3, TI−2 or TI−1), the healthy myocardium
presents a negative longitudinal magnetization value when the first α pulse is applied.
Nevertheless, the measured SI corresponds to the magnetization magnitude, so in fact the
healthy myocardium presents a higher signal intensity than the infarcted tissue. Thereby,
as the TI becomes shorter, the signal of infarcted tissue will decrease until it reaches the
null point. For an extremely short TI, the infarcted tissue appears null and the healthy
myocardium enhanced (TI−3). On the other side, an excessively long TI (TI1, TI2 or
TI3) can lead to a lack of contrast between tissues since the healthy myocardium signal
17
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Figure 2.10: (Top) Signal intensity over time for three different tissue types: healthy my-
ocardium, blood pool and infarcted tissue, considering multiple TI values. The signal magni-
tude directly depends on the TI chosen. (Down) DE-MR images correspondent to the different
TI values [28].
is not null. Both tissues will present a positive SI and consequently less image contrast.
For the optimal TI (TI0) the infarcted myocardium shows enhancement (image ar-
rows) while the healthy myocardium presents a null signal [28].
However, even if all these limitations are compensated for, one major limitation re-
mains. Since DE-MRI is cardiac triggered, irregular HR directly affects signal behaviour
causing strong image artefacts.
In the theoretical situation where HR is completely steady, the interval between R-
peaks is constant and so longitudinal magnetization has always the same time to recover.
Therefore, the signal intensity (Ma) is the same for all cardiac cycles.
However if the R-R length varies, the amount of time for the longitudinal magnetiza-
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tion to recover is different for each cycle (Fig. 2.11). If the R-peak occurs earlier than
usual, the time available for Mz to recover is shorter than To. Therefore the Ma available
at the next cycle will be higher. On the other hand, if the R-peak occurs later, Ma of
the following cycle will have a lower intensity.
In summary, varying R-R lengths will lead to a variation of the acquired MR signal
over several acquisition cycles.
Figure 2.11: Schematic representation of Mz behaviour over time in a repeated IR acquisition
considering two different tissue types: healthy myocardium (black solid line) and infarcted
myocardium (red solid line). For a patient with irregular heart rate, the cardiac cycles present
different lengths thereby influencing Mz behaviour.
Thereby when sampling K-space, different segments will be assigned with different
signal intensities (Ma) depending on their correspondent acquisition window (Fig. 2.12).
As a result, sampling K-space with different signal intensities leads to strong artefacts
when the final image is reconstructed.
To compensate for image artefacts due to HR irregularities is the main focus of this
thesis.
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Figure 2.12: Schematic representation of Mz behaviour over time using a repeated IR acqui-
sition with irregular heart rate. In each cardiac cycle an acquisition window (coloured circles)
is considered where several data points are acquired. On the right side of the image a represen-
tation of K-space linear sampling is shown. Different segments of K-space are filled with data
from their correspondent acquisition window. Different colouring of the segments/acquisition
windows represents different signal intensities.
2.5.1 Minimization of image artefacts due to irregular HR
A wide range of correction methods has been presented through the literature with posi-
tive outcome in reducing image artefacts due to irregular HR and incorrect nulling of the
myocardium.
A study by Krishnamurthy et al. reported positive results when applying a TI opti-
mization method to reduce artefacts in arrhythmic patients [8]. The method consisted in
dynamically adapting the TI for each acquisition cycle:
TIopt = ln(2/(1 + exp(−RR/T1))) ∗ T1 (2.8)
Where R-R describes the length of the previous cardiac cycle and T1 the relaxation
time of the tissue intended to be corrected. This formula was then used to accurately
correct the myocardium signal. The study reported a decrease in artefacts intensity of
180 % with adaptive TI correction when compared without a correction method. My-
ocardium/blood CNR also showed an improvement of approximately 70% with TI cor-
rection.
Another recent study reported an alternative approach to dynamic TI optimization,
where not only the TI is optimized for each cardiac cycle but also the inversion pulse
angle (αIR) is considered [7]. The degree of αIR applied directly influences the amount
of Ma available and thereby the final signal intensity acquired. Thereby, optimization of
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not only the TI but also the αIR can be useful to minimize signal irregularities.
TI optimization was be described by:
∆TIopt = T1ln
(
e
−T0
T1 − 2
e
−To−∆t
T1 − 2
)
(2.9)
Inversion pulse angles optimization was described by:
cos∆αIR =
e
−T0
T1 − 1
e
−T0−∆t
T1 − 1
(2.10)
With this optimization method, the study reported a reduction in the myocardium
signal deviation from the mean value of 15 % to 2, 5% [7,9].
However, both of these TI optimization methods are T1 dependent according to Equa-
tions 2.8 and 2.9. Thereby, selection of the optimal TI that correctly nulls the healthy
myocardium does not correspond to the optimal TI of the remaining tissues. Thus opti-
mal correction of the healthy myocardium only reduces image artefacts arising from the
healthy myocardium. Strong image artefacts may still arise due to signal variation of the
non-corrected tissues.
Thereby, the proposed method in this thesis intends to compensate not only for a
single tissue but multiple tissues simultaneously. By taking into account several tissues
signals when optimizing the TI, artefacts arising from different tissue can be corrected
and the overall artefacts level further reduced.
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IR DE-MRI simulation environment
3.1 Introduction and motivation
Due to DE-MRI wide range of medical applications and crucial role when assessing MI
patients, demand on image quality and artefact compensation methods has increased.
Nevertheless, a major limitation remains when imaging irregular heart rate patients.
If the heart rate is unsteady, signal intensity will be different for each acquisition cycle. In
this case, different segments of K space are sampled with different signal intensities leading
to strong artefacts when the final image is reconstructed (Section 2.5). The presence of
such artefacts decreases image quality and misleads clinical diagnosis, thereby being of
crucial importance to develop methods that aim to compensate for such artefacts.
Previous studies have presented compensation methods that dynamically adapt the TI
in order to guarantee that the signal from healthy myocardium is always null. However,
the choice of TI is T1 dependent and correcting for the healthy myocardium can still lead
to artefacts arising from other tissues that were not corrected.
Therefore, this project intends to develop a novel artefacts reduction method that
takes into account several tissue types. The main goal is to correct the TI for each
cardiac cycle such that signal intensity remains as constant as possible. A multi-tissue
approach is considered such that image artefacts arising from different tissue types can
all be reduced simultaneously. In addition, the method also considers adapting two
acquisition parameters (TI and α) to try to compensate for the maximum amount of
artefacts possible.
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For the purpose of this study, a simulation environment was built by the author,
modelling 2D DE-MRI acquisition using a cardiac triggered IR sequence.
The following sections of the this chapter present the methodology and results ob-
tained with the construction of such simulation environment.
3.2 Methodology
The built simulation environment comprehended several levels of organisation in different
functions such as: ECG triggering, mathematical description of a repeated IR sequence
signal (Section 3.2.1) and 2D image acquisition (Section 3.2.2).
The first modular function, (ECG triggering), was responsible for generating a virtual
ECG signal. Random time lengths between two consecutive R peaks were simulated with
a standard deviation (10 to 50 %) around the mean heart rate [7]. Both the mean heart
rate as well as the deviated distribution could be changed initially as input variables.
Thus allowing to simulate multiple situations from a steady HR to a more irregular HR.
This virtual ECG signal served as trigger to the following modular function (Section
3.2.1).
3.2.1 Mathematical description of a repeated IR signal
To allow for a quantitative prediction of the signal for different levels of HR irregularities,
a second modular function (IR sequence signal) modelled the MR signal behaviour for
an IR sequence (Section 2.4.3).
SI was determined taking into account the longitudinal magnetization at excitation
prior to data acquisition (Ma) as well as sequential calculation of transversal magnetiza-
tion (Mxy) and recovering longitudinal magnetization (Mz) over the acquisition window
in consecutive cardiac cycles.
Longitudinal magnetization at excitation (Mz,n) of cycle (n) directly depends on the
longitudinal magnetization available before the IR pulse at the end of the previous cycle
(n-1) (Mplus) [7] :
Mplus = 1 + (Mz,n−1 − 1)e
−T0−∆t
T1 (3.1)
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Mz,n = 1 + (Mpluscos(α)− 1)e−TIT1 (3.2)
Where T0 corresponds to the mean R-R interval length, α is the excitation flip angle
and ∆t describes the difference between the varying R-R length and the mean R-R length
(T0).
However during simulation implementation, the first cardiac cycle was set as an excep-
tion since there is no previous cycle to recover from. Thereby, longitudinal magnetization
at acquisition (Mz,n) was set to [7]:
Mz,n = 1 + [(1− e−To−∆tT1 )cos(180o)]e−TIT1 (3.3)
Nevertheless, equation 3.2 and equation 3.3 were only used to describe (Mz,n) for the
first data point acquired in each acquisition window.
The following points were calculated considering how the longitudinal magnetization
(Mz,n) recovers from the previous acquisition pulse (α) [35]:
Mz,n = Mz,n−1e
−TR
T1 cos(α) +Mz0(1− e−TRT1 ) (3.4)
Regardless of the data point, each longitudinal magnetization (Mz,n) is brought to
the xy-plane and the transversal magnetization (Mxy) can then be calculated [35]:
Mxy = Mz,ne
TE
T2∗ sin(α) (3.5)
The number of repeated Mz,n and Mxy calculations (data points acquired) per acqui-
sition window was set by the variable N (Section 2.4).
Since acquisition lasts for a period of time (TA), it directly depends on the number
of data points per window (N) and the time between consecutive excitations (TR):
TA = TR ∗N (3.6)
Both the TR and N could be changed at the start of simulation as input variables.
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3.2.2 Simulate 2D image acquisition
Signal behaviour at acquisition modelled earlier was then used to simulated 2D image
acquisitions.
This third modular function (2D image acquisition) required as input the simulated
ECG signal, the signal intensity previously calculated (Subsection 3.2.1), a numerical
phantom and a K-space sampling trajectory.
A numerical phantom was implemented to mimic a short-axis view of the left ventricle
representing three tissue types: fibrotic tissue, healthy myocardium and blood pool (Fig.
3.1).
Figure 3.1: Numerical phantom used in the simulation environment representing a short-axis
view of the left ventricle with three different tissue types: fibrotic tissue (F), blood pool (B)
and healthy myocardium (M).
The phantom was manually outlined from a scan image and a mask set to define the
outlines of each tissue. Each mask was assigned with intensity of 1 and the remaining
background set to zero. However for representation purposes, in Fig. 3.1 the tissue masks
were assigned different intensities.
Secondly, each tissue mask was assigned with the signal intensity calculated (Section
3.2.1) for the correspondent T1 value of that tissue. This was done for each data point
individually, followed by the sum of the three tissue specific signal masks. To the final
image thus obtained, a 2D fast Fourier transform (FFT) was applied resulting in the
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Parameters Value used
Mean heart rate 75 bpm
Matrix size 240 x 240 pixels
N factor 12 lines per window
Number of acquisition cycles 20
Fibrotic tissue (T1) 220 ms
Blood pool (T1) 310 ms
Healthy myocardium (T1) 550 ms
TE/TR 0/4.7 ms
Initial TI 270 ms
Initial excitation flip angle (α) 25 degrees
Start-up echoes 8
Upper boundary [40,450]
Lower boundary [0,150]
Table 3.1: Acquisition parameters used for simulations.
correspondent K-space matrix.
After this, the transformed K-space was modelled according to the chosen sampling
trajectory, re-organizing data points by the order of acquisition set by the sampling
trajectory. A simple linear cartesian trajectory was used in the simulation environment
in similarity to the one used by the scanner. Finally, an inverse fast Fourier transform
(IFFT) was applied to reconstruct the final image.
Parameter values used during simulation can be seen in Table 3.1. Upper and lower
boundaries variables refer to a set of values defined during the TI optimization method;
further description is available in Section 3.2.3. Since the T2* of the simulated tissues
were unknown and for simplicity reasons, the TE was considered null. It was assumed
that neglecting the T2 relaxation effect would not have a major effect on the final results,
however it is a limitation of the simulation environment.
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3.2.3 TI compensation method using a multi-tissue model
The method here suggested considers a multi-tissue approach of the dynamic TI opti-
mization. The main purpose was to optimize TI such that signal intensity of several
tissues remained as constant as possible.
This was achieved by minimizing the differences between the signal acquired with HR
variation (SItissue,%HRvariation) and the reference signal with no HR variation (SItissue,0%HRvariation).
This was accounted for using the Sum of Squared Error (SSE) for each tissue individually
(SSEtissue):
SSEtissue = Σ(SItissue,%HRvariation − SItissue,0%HRvariation)2 (3.7)
Since a multi tissue approach was considered, the sum of squares total error (SSEtotal)
was calculated taking into account the (SSEtissue) not only for the healthy myocardium
but for multiple tissues.
All three tissue types could have been taken into account, nevertheless from signal
behaviour results further discussed in Section 3.3.1, only the blood pool and healthy
myocardium were considered for the correction:
SSEtotal = W ∗ SSEmyocardium + (1−W ) ∗ SSEblood (3.8)
Where W (weighting factor) allows to correct more strongly for artefacts arising from
the healthy myocardium (W > 0.5) or from the blood pool (W < 0.5).
Thereby the main idea was to determine the optimal acquisition parameters (TIopt and
α) that correspond to the minimization of the (SSEtotal) which minimises irregularities
in Ma.
A MATLAB integrated script called fminsearchbnd was used to calculate the opti-
mized parameters. fminsearchbnd allows to search for the local minimum (X) around an
initial value (X0) of an input function (fun) with a set of upper and lower boundaries
(LB,UB):
[X] = fminsearchbnd(fun,X0, LB, UB); (3.9)
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In this study, this function was used for searching the value of TI (TIopt) that corre-
sponds to the minimum of the function (SSEtotal):
[TIopt, α] = fminsearchbnd(SSEtotal, parametersinitial, LB, UB) (3.10)
Where the array parametersinitial defined the initial parameters values around which
the function searches for a solution and [LB,UB] was the set of boundaries for the
parameters search. Specific values used for these variables are shown in Table 3.1.
In addition to only optimizing the TI, another scenario was also tested where both
acquisition parameters (TI and α) were optimized. Thus intending to study the effect
of optimizing the flip angles as a way to further improve image quality. In the Table
3.1, UB and LB refer to the values used when optimizing both the TI and the excitation
flip angle (α) simultaneously, where [0,40] boundaries refer to α and [150, 450] to TI. In
the case where the optimization of the TI was considered, UB and LB only included the
values [150] and [450].
3.2.4 Evaluation of signal deviation and image artefacts
The effect of irregular heart rate in signal behaviour was quantified by calculation of the
signal standard deviation. The standard deviation allowed to quantify how much the
signal deviates (σ) from the mean (µ) signal [36]:
σ =
√√√√ 1
N
N∑
i=1
(xi − µ)2 (3.11)
To obtain signal deviation percentage wise, σ was divided by µ and multiplied by 100.
Secondly, a method was devised to quantify image artefacts intensity (Fig. 3.2). A
reference image (simulated with steady HR) was subtracted to each simulated image with
HR variation. Thus obtaining an image that solely holds the artefacts intensity (Fig.3.2
(c)). The overall artefacts intensity was quantified by calculating the mean value of this
final image.
This quantification method of artefacts level was used to compare the our TI opti-
mization method with non-corrected images.
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Figure 3.2: (a) Simulated 2D image of the left ventricle considering a steady heart rate. (b)
Image simulated for 30% HR variation. Gray scale was adapted to visually enhance image
artefacts. (c) Image solely holding the artefacts intensity obtained subtracting image (a) from
image (b).
3.3 Results and discussion
3.3.1 Influence of irregular HR on signal behaviour and image
quality
Simulation of a repeated IR signal acquisition according with the experimental method-
ology described in section 3.2.1 was successfully accomplished. Signal intensity curves
were simulated with steady heart rate (reference signal) and with heart rate variation.
Reference signal along each acquisition window acquired with no heart rate variation
can be seen in Fig. 3.3 (a,b,c). As expected for a regular HR, all signal curves within
each tissue type showed the same intensity (signal curves overlap) meaning Ma remained
constant for all cycles.
For 30 % heart rate variation and no method of correction, signal curves showed
different intensities and no longer overlap (Fig. 3.3 (d,e,f)). This means that Ma was
irregular and the acquired signal presents different intensities.
In order to quantify the effect of irregular HR in signal behaviour, signal variation
was measured (Section 3.2.4) for all three tissue types considering different HR variation
values (Fig. 3.4).
Results shown that both HR variation and signal variation present a direct relation,
where a higher HR variation leads to a higher signal deviation, specially for the my-
ocardium (ex: 50 % HR relates to almost 90% signal deviation).
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Figure 3.3: Signal intensity (Y axis) along each acquisition window (X axis - 12 data points
per window) obtained through numerical simulation for three different tissue types: healthy
myocardium (green), blood pool (red) and fibrotic tissue (blue). (a,b,c) Reference signal ac-
quired with no heart rate (0 %) variation. (d,e,f) Signal acquired with heart variability (30 %)
and no method of correction applied. Signal variation is present when HR is unsteady.
Figure 3.4: Measurements of signal variation (Y-axis) from simulated data as a function of
heart rate variation (X-axis) for the three tissue types.
In addition, it was also concluded that HR variations seem to lead to a much stronger
signal variation for the blood and the myocardium rather than the fibrotic tissue. There-
fore, when implementing the multi-tissue TI optimization method (Equation 3.8), only
the blood and healthy myocardium signals were taken into consideration. Further results
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referring to the implementation of the TI correction method are presented in the following
Section 3.3.2.
Secondly, 2D DE-MRI images were simulated (Section 3.2.2) using a numerical phan-
tom and previously generated signal intensity curves.
2D simulated images representing short-axis view of the left ventricle can be seen
in Fig. 3.5. A reference image was simulated with 0 % heart rate variation where no
artefacts are visible (Fig. 3.5 (a)). The fibrotic tissue appears hyperenhanced compared to
the healthy myocardium (close to null) and the blood pool presents intermediate signal
intensity, as expected with delayed enhancement theoretical background. In addition,
analysis of Fig. 3.5 (a) confirms that a constant signal variation leads to an artefact-free
image since K-space was filled with a constant Ma.
On the contrary, for 30 % heart rate variation, artefacts were visible along the phase
encoding direction (Fig. 3.5 (b)). Therefore, irregular signal behaviour (Fig. 3.3 (d,e,f))
can be directly related with the presence of artefacts in the final image. The artefacts,
visually enhanced with a different gray scale, can be seen in Fig. 3.5 (c).
Figure 3.5: 2D images obtained through numerical simulation representing short-axis slice of
the left ventricle. (a) Reference image obtained with steady heart rate (0 % variation). The
infarcted myocardium showed enhancement compared to an almost nulled healthy myocardium
signal. (b) Image acquired with 30 % heart rate variation and no method of correction. Ghosting
artefacts are visible along the phase encoding direction of the image. (c) Image acquired with
30 % heart rate variation and no method of correction. Gray scale was adapted to visualize
image artefacts.
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3.3.2 Image artefacts reduction: dynamic TI optimization
The present subsection refers to the results obtained using the TI optimization method
previously described in Section 3.2.3. Two approaches were simulated, optimizing the
TI with a multi-tissue approach and for a single tissue, for comparison purposes to our
method.
Signal intensity curves were successfully simulated for 30% HR variations with TI
correction method.
Fig. 3.6 shows SI curves behaviour after TI optimization was used.
Figure 3.6: SI curves obtained through numerical simulations for three different tissue types:
healthy myocardium (green), blood pool (red) and fibrotic tissue (blue) with 30% HR vari-
ation. (a,b,c) TI optimization applied according to Equation 3.8 with W=1 (correcting for
myocardium). (d,e,f) TI optimization applied according to Equation 3.8 with W=0 (correcting
for blood).
However, these two first cases refer to using only one tissue signal in the correction
method. According to Equation 3.8, if W=1, only the healthy myocardium signal is
corrected. Fig. 3.6 (a,b,c) shows that myocardium SI curves overlap since TI optimization
made Ma constant over all cycles. Nevertheless, since only the myocardium signal was
taken into account for the correction, both the blood and fibrotic tissue still showed signal
variation.
On the other hand if W=0, only the blood signal was corrected. Fig. 3.6 (d,e,f)) shows
32
CHAPTER 3. IR DE-MRI SIMULATION ENVIRONMENT
HR variation (%) Fibrotic tissue Blood Myocardium
10 0,93 ± 0,14 0,0 ± 0,0 13,10 ± 1,37
20 2,02 ± 0,17 0,0 ± 0,0 23,63 ± 0,72
30 3,07 ± 0,15 0,0 ± 0,0 43,87 ± 2,78
40 2,45 ± 0,42 0,0 ± 0,0 40,85 ± 3,42
50 5,59 ± 0,56 0,0 ± 0,0 67,19 ± 6,38
Table 3.2: Signal variation measurements for different HR variation values considering the
three tissue types: fibrotic tissue, blood and healthy myocardium. TI optimization method for
W=0 was considered.
HR variation (%) Fibrotic tissue Blood Myocardium
10 3,22 ± 0,24 3,78 ± 0,24 0,0 ± 0,0
20 7,17 ± 0,38 8,53 ± 0,32 0,0 ± 0,0
30 11,22 ± 1,91 13,20 ± 1,96 0,0 ± 0,0
40 17,28 ± 1,70 19,21 ± 1,99 0,0 ± 0,0
50 26,69 ± 2,29 29,47 ± 3,76 0,0 ± 0,0
Table 3.3: Signal variation measurements for different HR variation values considering the
three tissue types: fibrotic tissue, blood and healthy myocardium. TI optimization method for
W=1 was considered.
the opposite situation where the blood SI curves overlap since Ma was made regular. Both
the healthy myocardium and fibrotic tissue SI curves still show signal variation.
Further signal variation measurements were performed for different HR variation val-
ues when applying W=0 and W=1 corrections. If W=0 (Table 3.2), blood signal shows
0% variation while other tissues show high level of variation (myocardium shows around
70% for 50% HR variation). If W=1 (Table 3.3), the myocardium signal shows steady
signal measurements while both fibrotic tissue and blood show variation (blood presents
30 % for 50 % HR variation). The present measurements seem to indicate that correcting
solely for one tissue type led to the presence of strong signal variation from the remaining
non-corrected tissues. In addition, correcting only for the healthy myocardium led to a
higher signal deviation of the fibrotic tissue even comparing with no correction method.
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Thereby, our multi-tissue TI optimization approach intends to look for a W factor
(0<W<1) that finds the best balancing correction between blood and myocardium signals,
relating to the maximum artefacts reduction possible.
In order to determine the best W factor, artefacts intensity level was measured for
different W values. Firstly, the artefacts intensity level measured for different W values
from the signal contribution of each tissue individually can be seen in (Fig. 3.7 (a)).
Similarly to signal behaviour results, if W=0, artefacts mainly arise from the healthy
myocardium since the blood signal is corrected. And if W=1, the artefacts mainly arise
due to the blood pool and a smaller portion due to the fibrotic tissue. Since at W=0
and W=1 the signals of blood and myocardium respectively were corrected, it should
be expected that for both W values, the artefacts level should be zero for the respective
tissues. However, a random level of noise was added to the simulated images and therefore
the slight detection of artefacts (intensity = 0.2) is due to the noise and not artefacts
specifically arising from the tissues since we measured the mean of the image background.
Secondly, evaluation of the artefacts intensity level measured when summing all tissues
together can be seen in Fig. 3.7 (b). A high level of artefacts was observed at W=0
and W=1 since correcting for only one of the tissues created artefacts arising from the
remaining tissues. The best W factor, correspondent to the minimum amount of artefacts,
was estimated as W=0.4.
Now considering W=0.4 as the best weighting factor, two methods of compensation
were analysed comparing the optimization of only the TI parameter or optimization of
both the TI and α.
One important aspect to keep in mind is that for the optimization of the excitation
flip angles (α), a ramp-up approach with start-up echoes was considered. This means
that only the last flip angle applied is optimized with our method. The remaining flip
angles along within the same acquisition window are then scaled towards the last pulse
(which was optimized). Thus 8 start-up pulses are calculated (beginning with 0o) plus
12 (N factor) more that correspond to the number of segments acquired per acquisition.
This type of implementation is more realistic and similar to what the scanner performs.
Measurements of signal variation for different HR variation values using both methods
of compensation can be seen in Fig. 3.8. It was concluded that for lower values of HR
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Figure 3.7: Artefacts mean intensity level (Y-axis) measured for different W factors (X-axis)
considering 30% heart rate variation. (a) Measured for the three tissues individually. (b)
Measured for the sum of all tissues.
variation, correction with only the TI or with both parameters showed similar signal
variation for all three tissue types. On the other hand, for higher irregularities of the HR
(> 40%), correction with both parameters showed to further reduce signal variation. This
was specially verified for the healthy myocardium where for 50 % HR variation, only TI
optimization resulted in 35% signal deviation while optimization with both parameters
reduced signal deviation to less than 25%. This can be explained by the fact that for a
higher HR variation, the non-corrected signal presents more variation since both factors
are correlated. Therefore the effect of adding the α parameter is more visible and further
improves signal correction.
Thus further results were simulated/acquired considering optimizing both acquisition
parameters to further reduce signal variation and image artefacts.
After determining the W=0.4 as the best weighting factor, a comparison can be
made with the non-corrected SI curves (Fig. 3.9). SI irregularities of the blood and
myocardium were compensated for successfully. Both signal curves (Fig. 3.9 (d,e)) showed
less variation in intensity comparing with the non-corrected curves (Fig. 3.9 (a,b)). Fig.
3.9 (c,f) shows that signal variation for fibrotic tissue at W = 0.4 is slightly larger than
with no correction method. This increase is outweighed by the improvement in reducing
artefacts caused by the myocardium and blood.
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Figure 3.8: Signal variation (Y-axis) measured for different HR variation (X-axis) values for
the three tissue types: healthy myocardium (green), blood pool (red) and fibrotic tissue (blue).
Two correction methods were under consideration: optimizing only the TI (dashed lines) or
optimizing both acquisition parameters (solid lines).
Figure 3.9: SI curves obtained through numerical simulations for three different tissue types:
healthy myocardium (green), blood pool (red) and fibrotic tissue (blue). (a,b,c) Signal along
each acquisition window acquired with heart variability (30 %) and no method of correction
applied. (d,e,f) Signal along each acquisition window acquired with heart variability (30 %).
TI and α optimization was applied with W=0.4.
Signal variation measurements (Fig. 3.10) lead to similar conclusions . A multi-tissue
approach proved to greatly reduce signal variation for both the blood and myocardium
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in comparison with absence of a correction method (Fig. 3.4) . For example, for 50% HR
variation, the myocardium signal showed a reduction from 90% to approximately 25%
while blood showed a reduction from 20% to less than 10%.
It was also verified that for the same HR variation, the fibrotic tissue signal showed a
slight increase from 5% to a little over 10% when applying the TI correction method. This
was expected since the fibrotic tissue signal was left uncorrected and thereby susceptible
to the HR irregularities, however the increase in signal variation is minimal.
Figure 3.10: Signal deviation measurements (Y-axis) for simulated data over different HR
variation values (X-axis). Measurements were made for all three tissue types.
Lastly, a reduction in signal variation with the TI optimization method resulted in
final simulated images with less visible artefacts.
2D simulated images with different W values can be seen in Fig. 3.11. Image corre-
sponding to the best W factor (Fig. 3.11 (c)) seems to present less artefacts than the
other two.
Measurements of image artefacts level for different W values according to method-
ology described in Section 3.2.4 were performed and previously shown in Fig. 3.7 (b).
Measurements of the simulated images showed that our multi-tissue approach (W=0.4)
image (Fig. 3.11 (c)) presented 70% less artefacts than a non-corrected image at 30%
HR variation. Corresponding to 20% less than W=0 (Fig. 3.11 (a)) and 30% less than
W=1 (Fig. 3.11 (b)).
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Figure 3.11: 2D images obtained through numerical simulation representing short-axis slice
of the left ventricle. All images were obtained with 30 % heart rate variation and gray scaling
was adapted to visually enhance artefacts. Correction method was applied with different W
values: W=0 (a) , W=1 (b) and W=0.4 (c).
In conclusion, the idea to keep in mind is that a multi-tissue tissue approach showed
not only to greatly reduced signal variation and image artefacts but to possible overcome
a single tissue approach. However, studies with phantom experiments (Chapter 4) were
necessary in order to validate conclusions drawn from simulated data.
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Phantom experiments
4.1 Introduction and motivation
The simulation experiments discussed in the previous chapter were evaluated on a clinical
3T MR scanner (Philips Healthcare, Best, The Netherlands) using gel tube phantoms.
4.2 Methodology
The multi-tissue correction approach was implemented on a clinical 3T MR scanner. Scan
experiments were performed using three gel phantom tubes representing the fibrotic tis-
sue, blood pool and healthy myocardium. Corresponding T1 values and other parameters
used for the phantom experiments are shown in Table 4.1.
The same virtual ECG signals used in the simulation were considered as triggering and
manually inserted into the scanner console when acquiring phantom data. The optimized
parameters for the multi-tissue approach were pre-calculated to ensure similar conditions
as the ones used in the simulations.
1D scan projections (Fig. 4.1) obtained at the scanner were used to calculate signal
intensity curves over each acquisition window.
The scan projections have a width correspondent to the width of each gel tube and
height correspondent to the total number of data segments necessary to sample one K-
space matrix. Each line is a projection of the signal intensity acquired for a single data
point onto the x-axis. The scanner organizes the data so that all first points acquired for
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Parameters Value used
Mean heart rate 75 bpm
Matrix size 240 x 240 x 8
N factor 12 lines per window
Number of acquisition cycles 20
TE/TR 2.26/4.7 ms
Fibrotic tissue (T1) 220 ms
Blood pool (T1) 450 ms
Healthy myocardium (T1) 650 ms
TI 270 ms
Initial excitation flip angle (α) 25 degrees
Start-up echoes 8
Table 4.1: Acquisition parameters used for phantom experiments acquisition.
Figure 4.1: Example of a 1D scan projection image acquired with 30% HR variation using three
gel phantoms representing the fibrotic tissue (left), the blood pool (middle) and myocardium
(right).
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all acquisition cycles are together (bottom rows) followed by all the second data points
acquired for all cycles and so on. Thereby the last set of lines (top rows) will then
represent the last data points for each acquisition cycles.
Measurements of each line in this 1D scan image allowed to obtain signal intensity
curves for each acquisition window similar to the ones obtained with the numerical sim-
ulation.
In addition, 2D images were also acquired with and without using the multi-tissue
correction approach for different W factors.
4.3 Results and discussion
4.3.1 Comparison to simulated signal behaviour
Firstly, in order to validate the simulation environment previously built, signal intensity
along each acquisition window for a steady HR was obtained through simulation environ-
ment and phantom experiments for different (α) values. For this situation, a different N
factor was considered (23 data points per window), however these measurements served
only to support simulation validity and not to be included in any main results. For all
further results, a N factor of 12 data points was used.
Fig. 4.2 shows similar curve behaviour between the simulated and acquired data for
all flip angle values. Thus validating the built simulation environment and proving to
be a real model of how the signal behaves in a real acquisition. As consequence, further
conclusions retained from the simulation data were considered to be reliable.
For the first set of experimental results, images of gel phantom tubes acquired with
1D scan mode can be seen in Fig. 4.3. For a steady HR, signal intensity is stable over
all acquisition windows thereby all data points within the same order position (all first
points, all seconds...etc.) present the same intensity. On 1D scan images this reflects as
a smooth transition of gray scale along the 1D scan length (Fig. 4.3 (a)). On the other
hand, with 30% HR variation, the signal is irregular and thereby data points within the
same order present different intensities presenting a striped pattern in a 1D scan image
(Fig. 4.3 (b)).
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Figure 4.2: Signal intensity curves for the fibrotic tissue considering a steady HR obtained
through the simulation environment (top row) and with phantom experiments (bottom row).
Figure 4.3: Image of 1D scan projections of three gel phantoms representing fibrotic tissue
(left), blood pool (middle) and healthy myocardium (right). (a) No heart rate variation (b) 30
% HR variation.
Secondly, signal intensity curves similar to the simulated ones, were obtained by mea-
surements of the 1D scan images. Acquired SI curves showed overlapping signal curves
for a steady HR situation (Fig.4.4 (a,b,c)) and signal variation at 30% HR variation (Fig.
4.4 (d,e,f)). Again, a stronger variation in signal intensity was found for blood pool and
myocardium rather than for the fibrotic tissue.
In order to quantify the effect of HR variation in the acquired signal behaviour, mea-
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Figure 4.4: Signal measurements from 1D scan projections for three tissue types: healthy
myocardium (green), blood pool (red) and fibrotic tissue (blue). (a,b,c) Reference signal along
each acquisition window acquired with no heart rate (0%) variation (d,e,f) Signal along each
acquisition window acquired with heart variability (30 %) and no method of correction applied.
surements of signal variation were performed as a function of different HR variation values
(Fig. 4.5). While for a steady HR, the signal showed negligible variation, a considerable
signal variation was visible specially for the blood pool and healthy myocardium for higher
values of HR variation. A slight difference was visible comparing to the same results ob-
tained for the simulated data (Fig. 3.4). It appears that the blood pool showed a much
higher signal variation in the phantoms experiments than in the simulation. This effect
is most probably due to deviation between the T1 value used at the simulation and the
T1 from the gel tube used for the experiments. However, a similar behaviour between
the two data types is still visible since the presence of HR variation directly relates to a
higher signal variation and the fibrotic tissue showed negligible variation compared with
the remaining tissues.
Thereby confirming the previously described conclusions, phantom experiments data
seem to confirme that HR variations lead to higher SI irregularities for healthy my-
ocardium and blood than for fibrotic tissue. Thus, implementation of the correction
method (Section 3.2.3) only took into account the signal from myocardium and blood.
In addition, the 2D images acquired with phantom experiments can be seen in Fig.
4.6.
The reference image shows three phantoms with T1 values similar to the ones used
on the simulated results (Fig. 4.6 (a)). Moreover as expected, the fibrotic tissue showed
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Figure 4.5: Measurements of signal variation (Y-axis) from phantoms experiments as a func-
tion of hear rate variation (X-axis) without correction for the three tissue types.
hyperenhancement while the healthy myocardium showed a nulled signal. In addition,
an enhancement of the edges was visible for the myocardium phantom image. This can
be explained by the transient TI effect. The selected TI is set to null the myocardium at
the beginning of the data acquisition. Nevertheless, data was acquired for 12*TR (56.4
ms) and during data acquisition the magnetization of the myocardium recovers further
leading to a signal from the myocardium greater than 0. At the end of the acquisition
window, the higher k-space frequencies are sampled with a non-null signal intensity, which
represent the fine details and edges of an image.
For 30 % HR variation and no correction applied, the scanner image shows a high
level of artefacts mainly arising from blood pool and myocardium (Fig. 4.6 (b)). Again,
a direct relation can be set between irregularities in myocardium and blood signals (Fig.
4.4 (d,e)) and image artefacts arising from the same tissue types (Fig. 4.6 (b)).
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Figure 4.6: 2D images acquired at 3T using experimental tube phantoms. (a) Reference image
obtained with steady heart rate (0 % variation). Each circle represents one tissue type according
to their T1 values: fibrotic tissue (bottom), blood pool (middle) and healthy myocardium (top).
(b) Image acquired with 30 % heart rate variation and no method of correction. Strong artefacts
are visible arising from the blood pool and healthy myocardium.
4.3.2 Image artefacts correction : dynamic TI optimization
Implementation of the TI optimization method with similar parameters was successful in
a 3T clinical scanner.
Experimental SI curves obtained with TI correction for W=0 and W=1 can be seen
in Fig.4.7. Improvements in signal variation can be seen for blood signal curve at W=0
(Fig. 4.7 (b)) and equally for the myocardium signal curve at W=1 (Fig. 4.7 (d)).
Nevertheless, complete correction of signal variation was not possible similar to what was
observed in the simulated results (Fig. 3.6). The T1 times of the gel phantoms were
previously determined using a Look Locker sequence [31]. Nevertheless, the incomplete
correction of the signal from the myocardium suggests that the T1 time of myocardium
was not determined correctly and thus the wrong T1 time value was used in the correction
formula.
Artefacts measurements for each tissue individually (Fig.4.8 (a)) showed similar con-
clusions to the simulated data. If W=0, artefacts arise mainly from healthy myocardium
while if W=1, artefacts arise from the blood signal. In addition similarly to simulation
data, for W=0 and W=1, the level of artefacts for the blood and the myocardium respec-
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Figure 4.7: SI curves obtained through phantom experiments for three different tissue types:
healthy myocardium (green), blood pool (red) and fibrotic tissue (blue) with 30% HR vari-
ation. (a,b,c) TI optimization applied according to Equation 3.8 with W=0 (correcting for
blood). (d,e,f) TI optimization applied according to Equation 3.8 with W=1 (correcting for
myocardium).
tively, is never zero due to the presence of random noise in the acquired images. Artefact
level for different W values considering the sum of all tissues confirmed the best weighting
factor to be 0.4 (Fig. 4.8 (b)). The scan results seem to suggest that the multi-tissue
approach (W=0.4) reduces the overall artefacts amount by more than 20-40 % compared
to a single-tissue correction approach.
Thereby, assuming W=0.4 as the best W factor, reflected in less deviated signal
intensity curves (Fig. 4.9). Both healthy myocardium and blood signal curves with TI
correction (W=0.4) present less variation than with no correction.
Then, measurements of signal variation for different HR variation values considering a
TI correction of W=0.4 and with both acquisition parameters (TI and α) were performed
for the scan experiments (Fig. 4.10). The multi-tissue approach revealed to greatly reduce
signal variation when comparing to the non-corrected situation (Fig. 4.5). For example,
for 30% HR, the blood presented a reduction from 70% to less than 40%. While for the
same situation, the healthy myocardium showed a reduction of signal variation from 55%
to less than 30%. The same phenomenon of increase in signal variation of the fibrotic
tissue was visible when correcting for W=0.4 since it it’s signal was left uncorrected.
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Figure 4.8: Artefacts intensity measured for different weighting values (W) for each tissue
individually (a) and summing all tissues (b).
Figure 4.9: Signal intensity for data acquisition through 1D scan projections from gel phan-
toms representing the three different tissue types: healthy myocardium (green), blood pool
(red) and fibrotic tissue (blue). (a,b,c) Signal along each acquisition window acquired with
heart variability (30 %) and no method of correction applied. (d,e,f) Signal along each acquisi-
tion window acquired with heart variability (30 %). TI optimization method was applied with
W=0.4
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Figure 4.10: Measurements of signal variation (Y-axis) from phantom experiments as a func-
tion of heart rate variation (X-axis) with TI correction W=0.4 for the three tissue types.
Images acquired with different weighting factors showed congruent results to SI curves
obtained with the same parameters.
For the application of the TI correction with W=0, blood signal was corrected and
artefacts mainly arise from healthy myocardium and fibrotic tissue (Fig. 4.11 (a)). On
the other hand if W=1, healthy myocardium signal was corrected and artefacts arise from
blood and fibrotic tissue (Fig. 4.11 (b)). Nevertheless, since myocardium T1 value could
had been wrongly estimated, the signal was not completely corrected and some artefacts
are still present. Image obtained with W=0.4 seems to present less artefacts than the
previous two (Fig. 4.11 (c)).
Again in accordance with the signal intensity curves previously shown, the 2D images
also show that a correction at W=0.4 creates more artefacts arising from the fibrotic
tissue. This occurs because since just the blood and myocardium signals were considered
for TI optimization, the fibrotic tissue signal is left completely uncorrected. Therefore
the fibrotic tissue high SI was highly affected by the HR variations. In addition, it is
important to keep in mind that the level of artefacts arising from the fibrotic tissue in a
in-vivo image would also be influenced by the extension of the lesion within the heart.
However, the fibrotic tissue usually covers a small extension compared to the healthy
myocardium and thereby the artefacts would probably have less impact than in these
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phantom images where all tissues have the same size. Nevertheless, it could also be
added as another parameter into the multi-tissue correction approach. Further studies
using in-vivo measurements are advisable to further analyse this aspect.
However, measurements (Fig. 4.8 (b)) showed that even with an increase in artefacts
arising from the fibrotic tissue, the proposed multi-tissue TI correction method reduces
image artefacts 20% to 45 % more than a single tissue approach, correcting for the blood
or the myocardium respectively.
Figure 4.11: 2D images acquired at 3T using experimental phantoms representing fibrotic
tissue (F), blood (B) and healthy myocardium (M). Images acquired with 30 % HR variations
with: (a) TI correction applied with W=0 (correcting blood) (b)TI correction applied with
W=1 (correcting healthy myocardium) (c) TI correction applied with W=0.4.
In conclusion, phantom experiments supported the conclusions obtained through sim-
ulation data. The novel multi-tissue TI optimization approach proved not only to greatly
reduce image artefacts in general but to possibly overcome a TI correction where only
the myocardium is corrected as in previous literature publications.
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Conclusions
DE-MRI has become a widely accepted tool in assessing several cardiac pathologies, being
highly important when evaluating therapeutic course and prognosis of cardiac patients.
A higher demand in medical applications motivated the research community to further
improve image quality reducing image artefacts.
Within this context, this dissertation presented a novel method for reducing image
artefacts in DE-MRI in patients with irregular heart rate.
A numerical simulation environment was built, allowing to model MR signal behaviour
in a repeated IR DE-MRI acquisition. 2D images were also simulated using a virtual ECG
signal, numerical phantom and analytic description of the MR signal behaviour during
DE-MRI scans.
The simulation environment was validated with data acquired on a clinical 3T Philips
scanner (Philips Healthcare, Best, The Netherlands). Simulation environment proved to
be a good model of real DE acquisition.
The first goal of the project was to study the effect of irregular heart rate on MR signal
behaviour and consequent image artefacts. This was accomplished both in simulated and
scanner data. Signal behaviour simulated/acquired with a steady HR showed constant
intensities over all cardiac cycles. On the other hand, signal behaviour with irregular HR
showed strong variation.
A direct connection was established where a higher HR irregularity generates a more
unsteady signal intensity behaviour. In addition, irregular HR also caused strong image
artefacts both in simulated and acquired data. It was observed that HR irregularities
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lead to a stronger signal deviation/image artefacts for the myocardium and blood signals
rather than the fibrotic tissue.
The second and main goal was to develop a novel method to reduce image artefacts. A
multi-tissue approach was presented where several tissues signal are corrected at the same
time. The W factor allowed to correct more strongly for artefacts from blood (W<0.5) or
myocardium (W>0.5). The W correspondent to the maximum artefacts reduction was
determined to be equal to 0.4. The image acquired with W=0.4 correction showed less
artefacts than the ones acquired with W=0 and W=1 (only one tissue corrected).
Simulation data measurements showed that, for a 30% HR variation, our multi-tissue
TI optimization method reduced overall artefacts by more than 70 % compared with a
non-corrected image. Moreover it reduced artefacts 20 to 30 % more than a single-tissue
approach where only the blood or the myocardium are corrected individually.
Experimental data also showed improvement in image quality. The multi-tissue ap-
proach reduced artefacts by 20% compared to correcting for only the blood (W=0) and
more than 45% when correcting for only the healthy myocardium (W=1).
In conclusion, this novel correction method not only has proven to greatly improve
DE image quality but also to possibly overcome previous literature methods where only
the healthy myocardium is corrected.
Results obtained in this study contributed to the scientific community aiming at
improving DE image quality. A poster and oral presentation were presented at the
European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) 2013
congress, held in Toulouse (France) in October 2013.
Despite the positive results obtained with this study, some limitations were present.
Inaccurate estimation of the T1 times of the gel phantoms could have led to a deviation
between simulated and phantom experiments data. Further research in the subject is
necessary in order to test T1 values of the phantoms, parameters used in the simulation
and implementation in in-vivo image acquisition. Aspects as varying the mean heart rate
to higher and lower values, testing different K-space sampling trajectories and gating
methods could be interesting to study in the future. In addition, determination of the
optimal W factor for in-vivo imaging is necessary.
51
Bibliography
[1] A. Arai P. Kellman. Cardiac imaging techniques for physicians: late enhancement.
Journal of magnetic resonance imaging, 36(3):529–542, September 2012.
[2] R. Judd R. Kim, D. Shah. How we perform Delayed Enhancement imaging. Journal
of Cardiovascular Magnetic Resonance, 5(3):505–514, May 2003.
[3] J S Detsky, J a Stainsby, R Vijayaraghavan, J J Graham, a J Dick, and G a Wright.
Inversion-recovery-prepared SSFP for cardiac-phase-resolved delayed-enhancement
MRI. Magnetic resonance in medicine : official journal of the Society of Magnetic
Resonance in Medicine / Society of Magnetic Resonance in Medicine, 58(2):365–72,
August 2007.
[4] L. Hsu Y. Chung O. Simonetti E. McVeigh A. Arai P. Kellman, A.C. Larson.
Motion-corrected free-breathing delayed enhancement imaging of myocardial infarc-
tion. Magnetic resonance in medicine, 53(1):194–200, January 2005.
[5] J. Post G. Yo J. Verwoerd L. Kroft A. Roos H. Van den Bosch, J. Westenberg.
Free-breathing MRI for the assessment of myocardial infarction: clinical validation.
AJR. American journal of roentgenology, 192(6):W277–81, June 2009.
[6] R. Kim F. Saremi, J. Grizzard. Optimizing cardiac MR imaging: practical remedies
for artifacts. Radiographics : a review publication of the Radiological Society of North
America, Inc, 28(4):1161–1187, 2008.
[7] J. Burakiewicz. Artifact reduction in cardiac MRI in patients with varying heart
rate. Master’s thesis, 2010.
52
BIBLIOGRAPHY
[8] J. Smink B. Cheong R. Muthupillai R. Krishnamurthy, A. Pednekar. Arrhythmia
insensitive inversion recovery preparation (IR-prep)with real-time adaptive inver-
sion delay (TI):phantom validation. Journal of Cardiovascular Magnetic Resonance,
12:168, 2010.
[9] G. D. Charles-Edwards T. Schaeffter J. Burakiewicz, C. Kolbitsch. Reducing arte-
facts inversion recovery prepared MRI caused by varying heart rate through real-time
adaptation of the inversion time. In the Proceedings of the 19th Annual Meeting of
ISMRM, page 4620, 2011.
[10] K. Kissinger B. Goddu S. Berg W. Manning R. Nezafat S. Weinga¨rtner, M. Akc¸akaya.
Combined saturation/inversion recovery sequences for improved evaluation of scar
and diffuse fibrosis in patients with arrythmia or heart rate variability. Proceedings
of the 21st Annual Meeting of ISMRM 2013, page 257, 2013.
[11] M. Roth J. Goldfarb, S. Arnold. Gadolinium pharmacokinetics of chronic myocardial
infarcts: Implications for late gadolinium enhanced infarct imaging. Journal of
magnetic resonance imaging : JMRI, 30(4):763–770, October 2009.
[12] V.D. Ko¨chli D. Weishaupt. How Does MRI Work ? An Introduction to the Physics
and Function. Springer, 2006.
[13] World Health Organization. The top 10 death causes in the world, August.
[14] National hear lung institute. What is coronary heart disease, August 2013.
[15] B. Knowles. The Visualisation and Characterisation of Cardiac Lesions using Mag-
netic Resonance Imaging . PhD thesis, 2010.
[16] K. Wu J. Vogel-claussen, C. Rochitte. Delayed Enhancement MR Imaging : utility
in myocardial assessment. Radiographics, 26:795–811, 2006.
[17] Hajime Sakuma. Magnetic resonance imaging for ischemic heart disease. Journal of
magnetic resonance imaging, 26(1):3–13, July 2007.
53
BIBLIOGRAPHY
[18] T.A. Holly A. Wagner, H. Mahrholdt. Ce-mri and routine single photon emission
computed tomography (spect) perfusion imaging for detection of subendocardial
myocardial infarcts: an imaging study. Lancet, 361:374–379, 2003.
[19] A. Rafael R.J. Kim, E. Wu. The use of contrast-enhanced magnetic resonance
imaging to identify reversible myocardial dysfunction. N Engl J Med, 343:1445–
1453, 2000.
[20] E.L. Chen J.W. Lomasney K.J. Klocke R.M. Judd D.S. Fieno, R.J. Kim. Contrast-
enhanced magnetic resonance imaging of myocardium at risk: distinction between
reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol,
36:1985–1991, 2000.
[21] W.G. Rehwald T. Albert R.J. Kim M.J. Robert, A. Wagner. Technology insight: as-
sessment of myocardial viability by delayed-enhancement magnetic resonance imag-
ing. Nat Clin Pract Cardiovasc Med, 2:150–158, 2005.
[22] T.B. Parrish K. Harris E.L. Chen O. Simonetti J. Bundy J.P. Finn F. Klocke
R.M. Judd R.J. Kim, D.S. Fieno. Relationship of MRI Delayed Contrast En-
hancement to irreversible injury, infarct age and contractile function. Circulation,
100(19):1992–2002, November 1999.
[23] Schulz-Menger J H. Abdel-Aty H, Zagrosek A. Delayed enhance- ment and t2-
weighted cardiovascular magnetic resonance imaging differentiate acute from chronic
myocardial infarction. Circulation, 109:2411–2416, 2004.
[24] G. Gubernikoff G-J.D. Vargas M. Parker R.M. Judd K.M. Choi, R.J. Kim. Trans-
mural extent of acute myocardial infarction predicts long term improvement in con-
tractile function. Circulation, 104:1001–1007, 2001.
[25] D.A. Bluemke K.C. Wu J.A. Lima B.L. Gerber, J. Garot. Accuracy of contrast-
enhanced magnetic resonance imaging in predicting improvement of regional myocar-
dial function in patients after acute myocardial infarction. Circulation, 106:1083–
1089, 2002.
54
BIBLIOGRAPHY
[26] Pound Bloembergen, Purcell. Relaxation effects in nuclear magnetic resonance ab-
sorption. Phys Rev, 73:679–712, 1948.
[27] M. Graves M. Prince D. McRobbie, E. Moore. MRI From Picture to Proton. Cam-
bridge university press edition, 2006.
[28] J. Babb O. Simonetti V. Lee, Y. Chung. Myocardial infarction : optimization of
inversion times at delayed contrast-enhanced MR imaging. pages 921–926, 2004.
[29] J. Weaver A. Stillman O. Simonetti R. White R. Setser, Y. Chung. Effect of inversion
time on delayed-enhancement magnetic resonance imaging with and without phase-
sensitive reconstruction. Journal of magnetic resonance imaging : JMRI, 21(5):650–
655, May 2005.
[30] M. Frohlich R. Dietz J. Schulz-Menger D.R. Messroghli, A. Greiser. Optimization
and validation of a fully-integrated pulse sequence for modified look-locker inversion-
recovery (molli) t1 mapping of the heart. J Magn Reson Imaging, 26:1081–1086,
2007.
[31] D.C. Look. Time saving in measurement of NMR and EPR relaxation times. Review
of Scientific Instruments, 41(2):250, 1970.
[32] W. Mu¨tzel H.J. Weinmann, M. Laniado. Pharmacokinetics of
GdDTPA/dimeglumine after intravenous injection into healthy vol- unteers.
Physiol Chem Phys Med NMR, 16:167–172, 1984.
[33] T. Holly M. Elliott R. Bonow-R. Kim R. Judd H. Mahrholdt, A. Wagner. Re-
producibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic
Resonance Imaging. Circulation, 106:2322–2327, 2002.
[34] J.R. Jones J. Mata B. French J.N. Oshinski, Z. Yang. Imaging time after Gd-DTPA
injection is critical in using Delayed Enhancement to determine infarct size accurately
with magnetic resonance imaging. Circulation, 104(23):2838–2842, December 2001.
[35] R. Busse S. Majumdar X. Li, E. Han. In vivo T1 mapping in cartilage using 3D
magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo
55
BIBLIOGRAPHY
snapshots (3D MAPSS). Magnetic resonance in medicine, 59(2):298–307, March
2008.
[36] WolframAlphaMathWorld. Standard deviation, September 2013.
56
